Interview with Jan B. Vermorken, MD, PhD | Belgium

Overview
Dr. Jan B. Vermorken provides his perspective on the recent and emerging advances in induction and maintenance therapy in head and neck cancer. He also discusses current studies related to the treatment of patients who are HPV-positive and HPV-negative and the future advances in those areas.

- Lyudmila Bazhenova, MD
  Peer
- Benjamin Levy, MD
  Peer
8
CME/CE
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
- Shira Johnson, MD
  Peer
- Robert Vonderheide, MD
  Peer
25
Medical Breakthroughs from Penn Medicine
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
- Matt Birnholz, MD
  Peer
- Taine Pechet, MD
  Peer
14
Medical Breakthroughs from Penn Medicine
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung …
12
The JAMA Report™
New Recommendations for Colorectal Cancer Screening
New Recommendations for Colorectal Cancer Screening
New Recommendations for Colorectal Cancer Screening

Prova Education